期刊文献+

血清IL-31表达水平与慢性自发性荨麻疹患者病变严重程度、瘙痒程度和生活质量的相关性研究 被引量:10

The correlation between serum IL-31 expression level and severity, pruritus and quality of life in patients with chronic spontaneous urticaria
原文传递
导出
摘要 目的探讨血清IL-31水平与慢性自发性荨麻疹病变严重程度、瘙痒程度和生活质量的相关性。方法选取2015年12月-2018年12月余姚市人民医院皮肤科收治的180例慢性自发性荨麻疹患者和同期60例健康体检者为研究对象,根据患者病情,将患者分为轻度组(60例)、中度组(60例)和重度组(60例),比较各组患者血清IL-31水平差异情况,对患者进行7 d综合症状积分、VAS和CU-Q2oL评分。统计分析患者血清IL-31水平与7 d综合症状积分、VAS评分和CU-Q2oL评分之间的相关性。结果健康体检者血清IL-31水平为(7.63±0.85)pg/mL,显著低于慢性自发性荨麻疹患者水平[(25.14±3.50)pg/mL,P<0.05]。轻度组、中度组和重度组患者血清IL-31水平依次增高[(17.66±2.05)pg/mL、(23.70±3.13)pg/mL和(28.77±3.62)pg/mL],差异具有统计学意义(P<0.05)。Person相关性分析显示,血清IL-31水平与慢性自发性荨麻疹患者7 d综合症状积分、VAS评分和CU-Q2oL评分均呈正相关性(r=0.658~0.795,P=0.008~0.020)。结论 IL-31在慢性自发性荨麻疹患者的致痒机制中可能具有重要作用,对病变的严重程度和患病后的生活质量均有影响。 Objective To investigate the correlation between serum IL-31 expression level and severity, pruritus and quality of life in patients with chronic spontaneous urticaria. Methods A total 180 patients with chronic spontaneous urticaria and 60 health examinees admitted to dermatology department of our hospital from December 2015 to December 2018 were selected as the research objects. According to the patient’s condition, the patients were divided into mild group(60 cases), moderate group(60 cases) and severe group(60 cases). The difference of serum IL-31 levels in each group was compared. The patients were scored with 7-day comprehensive symptom score, VAS and CU-Q2 oL score. The correlation between serum IL-31 level and 7 d symptom score, VAS score and CU-Q2 oL score was tested. Results The serum level of IL-31 in healthy subjects(7.63±0.85) pg/mL was significantly lower than that in patients with chronic spontaneous urticaria(25.14±3.50) pg/mL(P<0.05). The serum IL-31 levels in the mild, moderate and severe groups increased in turn Serum IL-31 levels in mild, moderate and severe groups increased in turn(17.66±2.05, 23.70±3.13 and 28.77±3.62) pg/mL, with statistical significance(P<0.05). Person correlation analysis showed that serum IL-31 level was positively correlated with 7-day syndrome score, VAS score and CU-Q2 oL score in patients with chronic spontaneous urticaria(r=0.658-0.795, all P<0.05). Conclusion IL-31 may play an important role in the itching mechanism of patients with chronic spontaneous urticaria, and may affect the severity of the lesion and the quality of life after the disease.
作者 谷锋 沈云良 GU feng;SHEN Yun-liang(Department of Dermatology,Yuyao People's Hospital,Ningbo,Zhejiang 315400,China)
出处 《中华全科医学》 2019年第9期1527-1529,共3页 Chinese Journal of General Practice
基金 2017年浙江省医药卫生科技计划项目(2017KY042)
关键词 白细胞介素-31 慢性自发性荨麻疹 瘙痒 生活质量 相关性 Interleukin-31 Chronic spontaneous urticaria Pruritus Quality of life Correlation
  • 相关文献

参考文献10

二级参考文献57

  • 1Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/ EDF/WAO Guideline: definition, classification and diagnosis of urticaria[ J]. Allergy,2009,64 : 1417 - 1426.
  • 2Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/ EDF/WAO guideline: definition, classification and diagnosis of ur- ticaria[J]. Allergy, 2009, 64: 1417-1426.
  • 3Ciprandi G, De Amici M, Berardi L, et al. Serum neopterin levels in spontaneous urticaria and atopic dermatitis[J]. Clin Exp Dermatol, 2011, 36: 85-87.
  • 4Miescher SM, Horn MP,Pachlopnik JM, et al. Natural anti-Feep- silonRIalpha autoantibodies isolated from healthy donors and hronic idiopathic urticaria patients reveal a restricted repertoire and au- toreactivity on human basophils[J]. Hum Antibodies, 2001, 10:119- 126.
  • 5Horn MP, Pachlopnik Jm, Vogel M, et al. Conditional autoimmunity mediated by human natural anti-FceRIa autoantibodies?[J]. FASEB J, 2001,15: 2268-2274.
  • 6Katz Y, Nadir O, Papoport M, et al. IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts[J]. Clin Exp Immunol, 2000, 120: 22-29.
  • 7Andrews E, Feldhoff P, Feldhoff R, et al. Comparative effects of cy- tokines and cytokine combinations on complement component C3 secretion by HepG2 cells[J]. Cytokine, 2003, 23: 164-169.
  • 8Savic S, Marsland A, McKay D, et al. Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care [ J ]. Al- lergy Asthma Clin Immunol,2015,11 ( 1 ) :21.
  • 9Asero R,Pinter E, Marra AM, et al. Current challenges and controver- sies in the management of chronic spontaneous urticaria [ J ]. Expert Rev Clin lmmuno1,2015 : 1-10.
  • 10Kaplan AP, Joseph K, Saini SS. How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria[ J]. J Allergy Clin Immunol Pract,2015,3(4) :648.

共引文献108

同被引文献104

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部